Configuring Study Reporting
Study Reporting is provided in the Study Configuration section to configure study-based reporting requirements.
The reporting rules are not directly defined in the study, but rather identify which reporting rules to check from the already configured expedited reporting rules.
The identification is based on specifying what set of reporting rules to evaluate, as per the criteria of:
- Country
- License Type
- Reporting Destination
Study reporting is available for both Who Drugs and J Drugs. When you are a Japanese
user and you click the Add button in either the English or
the Japanese Study Reporting section, the following scenarios may occur:
- If the reporting destination contains WHO Drug or J Drug reporting, then you can add a record.
- If the reporting destination does not contain WHO drug or a J drug
reporting, the following error message is displayed:
There are no Reporting Destinations for which WHO Drug reporting or J Drug reporting is configured.
The Japanese error message reads:WHO Drug報告またはJ Drug報告が構成されている報告先がありません
Use the following procedure to configure study based reporting.
Parent topic: Configuring Clinical Studies